36 results on '"Rana, Zaker"'
Search Results
2. Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer
3. Conditional Risk and Predictive Factors Associated With Late Toxicity in Patients With Prostate Cancer Treated With External Beam Radiation Therapy Alone in the Randomized Trial RTOG 0126
4. Racial Analysis of Clinical and Biochemical Outcomes in Patients With Prostate Cancer Treated With Low-Dose-Rate Brachytherapy
5. WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer
6. Proton Pencil Beam Scanning Facilitates the Safe Treatment of Extended Radiation Targets for Hodgkin Lymphoma: A Report from the Proton Collaborative Group Registry.
7. Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer
8. Impact of stereotactic body radiation therapy on geriatric assessment and management for older patients with head and neck cancer using G8
9. Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase 1 Trial for Patients With Low- and Intermediate-Risk Prostate Cancer
10. Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer
11. Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes
12. Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer
13. Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.
14. Genomic biomarkers to guide precision radiotherapy in prostate cancer.
15. High-risk, recurrent and oligometastatic prostate cancer: recent developments on the role of radiation.
16. Computed tomography-based flap brachytherapy for non-melanoma skin cancers of the face.
17. Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer.
18. Quality of Life Outcomes Following Organ-Sparing SBRT in Previously Irradiated Recurrent Head and Neck Cancer.
19. Conditional Risks of Biochemical Failure and Prostate Cancer–Specific Death in Patients Undergoing External Beam Radiotherapy: A Secondary Analysis of 2 Randomized Clinical Trials.
20. Major complications from radiotherapy following treatment for atypical meningiomas.
21. Outcomes and Toxicity Following Salvage Low-Dose-Rate Brachytherapy for Recurrent Prostate Cancer after Radiation Therapy
22. P16 - Outcomes After Gamma Knife Radiosurgery for Intracranial Meningiomas
23. (P20) Decreased PSA Nadir as a Result of Dose-Escalated Stereotactic Body Radiation for Patients With Low- and Intermediate-Risk Prostate Cancer
24. (OA18) Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase I/II Trial for Patients With Low- and Intermediate-Risk Prostate Cancer
25. Phase 2 randomized total eradication of metastatic lesions following definitive radiation to the prostate in de novo oligometastatic prostate cancer (TERPs) trial.
26. Genomic determinants of patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer.
27. Prognostic impact of circulating tumor cells in oligometastatic hormone-sensitive prostate cancer following metastasis-directed therapy.
28. Strut-Based Vs. Balloon-Based Brachytherapy: Hotspots, Skin Doses, and Rib Doses
29. Sexual, irritative, and voiding outcomes, following stereotactic body radiation therapy for prostate cancer.
30. Comparative dosimetric findings using accelerated partial breast irradiation across five catheter subtypes.
31. Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancer.
32. (P037) Treatment of Prognostically Favorable Peripheral Nerve Sheath Tumors: A Single-Institution Experience.
33. Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer.
34. Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712.
35. Burnout in Radiation Oncology Physician Workforce: The Effect of Mindfulness and Fulfillment.
36. Outcomes in the radiosurgical management of metastatic spine disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.